Edit |   |
---|---|
Antigenic Specificity | Pseudomonas aeruginosa Serotype IATS O12 (Panobacumab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgM kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Panobacumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Pseudomonas aeruginosa Serotype IATS O12, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Panobacumab is under investigation in clinical trial NCT00851435 (Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa). |
Immunogen | n/a |
Other Names | Panobacumab, Pseudomonas aeruginosa Serotype IATS O12, 885053-97-4 |
Gene, Accession # | CAS: 885053-97-4 |
Catalog # | abx831130 |
Price | please inquire |
Order / More Info | Pseudomonas aeruginosa Serotype IATS O12 (Panobacumab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950